Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [3413]

ASCO 2016: Expert discussion on the latest on multiple myeloma

Dr Sagar Lonial and Dr Paul Richardson

ASCO 2016: Expert discussion on the latest on multiple myeloma ( Dr Sagar Lonial and Dr Paul Richardson )

Trial of proposed trastuzumab biosimilar, MYL-1401O vs herceptin

Dr Hope Rugo - University of California, San Francisco, USA

Trial of proposed trastuzumab biosimilar, MYL-1401O vs herceptin ( Dr Hope Rugo - University of California, San Francisco, USA )

Controlled phase III trial of adjuvant combination chemotherapy of gemcitabine...

Prof John P. Neoptolemos - University of Liverpool, Liverpool, UK

Controlled phase III trial of adjuvant combination chemotherapy of gemcitabine and capecitabine, versus monotherapy gemcitabine in patients with resected pancreatic ductal adenocarcinoma ( Prof John P. Neoptolemos - University of Liverpool, Liverpool, UK )

Randomised double blind phase III safety and efficacy trial of the proposed...

Dr Hope Rugo - University of California, San Francisco, USA

Randomised double blind phase III safety and efficacy trial of the proposed trastuzumab biosimilar, MYL-1401O vs. herceptin ( Dr Hope Rugo - University of California, San Francisco, USA )

Hodgkins - update on treatment strategies in children and adolescents

Prof Christine Mauz-Körholz - University of Giessen, Giessen, Germany

Hodgkins - update on treatment strategies in children and adolescents ( Prof Christine Mauz-Körholz - University of Giessen, Giessen, Germany )

Use of novel agents in childhood ALL

Prof Lia Gore - Children's Hospital Colarado, Aurora, USA

Use of novel agents in childhood ALL ( Prof Lia Gore - Children's Hospital Colarado, Aurora, USA )

Oncology for children: what can be done when resources are scarce?

Prof Elizabeth Molyneux - Queen Elizabeth Central Hospital, Blantyre, Malawi

Oncology for children: what can be done when resources are scarce? ( Prof Elizabeth Molyneux - Queen Elizabeth Central Hospital, Blantyre, Malawi )

Relapsed Hodgkin lymphoma in PET positive patients

Dr Graham Collins - Oxford University Hospitals NHS Foundation Trust, Oxford, UK

Relapsed Hodgkin lymphoma in PET positive patients ( Dr Graham Collins - Oxford University Hospitals NHS Foundation Trust, Oxford, UK )

Entrectinib, a novel treatment for TRK fusions, shows early promise against a...

Dr Alexander Drilon - Memorial Sloan Kettering Cancer Center, New York, USA

Entrectinib, a novel treatment for TRK fusions, shows early promise against a range of cancer types ( Dr Alexander Drilon - Memorial Sloan Kettering Cancer Center, New York, USA )

First outcome results from MINDACT breast cancer clinical trial

Dr Martine Piccart - Jules Bordet Institute, Brussels, Belgium

First outcome results from MINDACT breast cancer clinical trial ( Dr Martine Piccart - Jules Bordet Institute, Brussels, Belgium )

A presurgery combination therapy may improve outcomes for women with Her2...

Dr Angela DeMichele - Perelmen School of Medicine, University of Pennsylvania...

A presurgery combination therapy may improve outcomes for women with Her2-positive breast cancer ( Dr Angela DeMichele - Perelmen School of Medicine, University of Pennsylvania, Philadelphia, USA )

5 year survival rates for nivolumab-treated metastatic melanoma patients much...

Dr Stephen Hodi - Dana-Farber Cancer Institute, Boston, USA

5 year survival rates for nivolumab-treated metastatic melanoma patients much higher than historical rates ( Dr Stephen Hodi - Dana-Farber Cancer Institute, Boston, USA )

More from ecancer